title: Molecular mechanisms of melanoma.
authors: Amanda
authors: A
authors: Pickert
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic; D003880:Dermatology / Q000193:education*; D019317:Evidence-Based Medicine; D005784:Gene Amplification; D011905:Genes, ras / Q000235:genetics; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D007396:Internship and Residency; D008545:Melanoma / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D009361:Neoplasm Invasiveness; D010770:Phosphotransferases / Q000235:genetics* / Q000378:metabolism; D011379:Prognosis; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D015398:Signal Transduction; D012878:Skin Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism; D013449:Sulfonamides / Q000627:therapeutic use; D014158:Transcription, Genetic; D016896:Treatment Outcome; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; D010770:Phosphotransferases; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf